UACC893(人乳腺癌细胞)
CBP60398
询 价
索取STR
产品描述
产品数据库
I. General information | |
Synonyms: | UACC893 |
Background: | This cell line was established by A. Liebovitz and associates in 1987 from breast tissue removed at lumpectomy to remove a ductal carcinoma (stage II). |
Species: | Homo sapiens, human |
Tissue: | mammary gland; breast |
Disease: | primary ductal carcinoma |
Gender: | Caucasian, 57 years, female |
Morphology: | epithelial |
Growth Mode: | adherent |
Doubling Time: | 100 hrs |
DNA Profile: | Amelogenin: X CSF1PO: 11,12 D13S317: 13 D16S539: 9,13 D5S818: 12 D7S820: 11 THO1: 6,9.3 TPOX: 8 vWA: 16,17 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
DMEM+10%FBS UACC893完全培养基,# CBP60398M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | N/A |
Receptor Expression: | N/A |
Oncogene: | N/A |
Genes Expressed: | N/A |
Cellular Products: | N/A |
Tumor Formation: | N/A |
Comments: | The cells exhibit a 20 fold amplification of the HER-2/neu oncogene sequence. The cells grow very slowly, and growth can be enhanced by using 20% fetal bovine serum and adding epidermal growth factor (10 ng/mL) to the medium. They are negative for estrogen receptors, progesterone receptors and P glycoprotein. For more information, please contact Cobioer (4008-750-250). |